Diflorasone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28F2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T2DHJ9645W, chemically known as 6alpha-fluorobetamethasone-17,21 diacetate but generally known as diflorasone, which bears US NIH Compound Identifier 71414. European Medicines Agency schedules Diflorasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07126MIG. World Health Organization schedules diflorasone in its Anatomical Therapeutic Chemical (ATC) Classification. DIFLORASONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diflorasone under HS 29372200 and SITC 54153. As of Q4 2014, DIFLORASONE remains the US FDA Preferred Term for this commodity. Diflorasone bears US NLM identifiers UMLS ID C0304612 and NCI Concept Code C61722. SMILES: FC12C(C3C(C(OC(=O)C)(C(C3)C)C(=O)COC(=O)C)(CC1O)C)CC(F)C1=CC(=O)C=CC21C.